Andreas Schmidt

Managing Director, Springboard Ventures

Dr. Andreas Schmidt is a serial entrepreneur with a track record of building deep tech startups across Asia, Europe, and the United States. He is the Managing Director of Springboard Health Ventures, a venture capital firm and global angel network focused on health technology innovation.

After successfully leading Proteona to its acquisition by Singleron Biotechnologies, he assumed responsibility for global business development at Singleron, driving the application of single-cell technologies in precision medicine.

Dr. Schmidt is actively involved in multiple startups worldwide as a board member, mentor, and shareholder. He holds a PhD in Immunology from the University of Cologne and University of California Berkeley, and was among the early entrepreneurs within the Singapore-MIT Alliance for Research and Technology (SMART) initiative. His engagements are focussed on new approaches to precision medicine, multi-omics platforms, cell therapy and artificial intelligence enabled clinical research.